ZANABONI, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 521
EU - Europa 263
AS - Asia 174
OC - Oceania 1
SA - Sud America 1
Totale 960
Nazione #
US - Stati Uniti d'America 517
IE - Irlanda 182
CN - Cina 163
IT - Italia 26
FI - Finlandia 16
DE - Germania 12
SE - Svezia 6
UA - Ucraina 5
CA - Canada 4
CZ - Repubblica Ceca 4
GB - Regno Unito 4
SG - Singapore 4
BE - Belgio 3
HU - Ungheria 2
TR - Turchia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 960
Città #
Dublin 182
Chandler 168
Ashburn 46
Nanjing 32
Beijing 30
Lawrence 24
Medford 24
Princeton 24
Shanghai 24
Boardman 23
Jacksonville 17
Nanchang 14
Wilmington 13
Changsha 12
Hebei 11
Jiaxing 11
Ann Arbor 10
Helsinki 10
Shenyang 9
Hangzhou 8
Washington 6
Los Angeles 5
Tianjin 5
Brno 4
Norwalk 4
Brussels 3
Milan 3
Phoenix 3
Redwood City 3
Rivoli 3
Seattle 3
Toronto 3
Turin 3
Woodbridge 3
Borås 2
Chicago 2
Des Moines 2
Fairfield 2
Jinan 2
Munich 2
New York 2
Orange 2
Pavia 2
Singapore 2
Adliswil 1
Berlin 1
Budapest 1
Central 1
Concorezzo 1
Dearborn 1
Düsseldorf 1
Hanoi 1
Houston 1
Melbourne 1
Qingdao 1
Riyadh 1
Rome 1
San Francisco 1
Shenzhen 1
São Paulo 1
Vienna 1
Winnipeg 1
Zanjan 1
Zhengzhou 1
Totale 783
Nome #
Microarray analysis on peripheral blood mononuclear cells of coeliac patients 77
Blocco combinato di coattivazione e costimolazione: una strategia utile nell'induzione di tolleranza alloantigene - specifica 58
Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury 55
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model 54
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 52
Microarray analysis of peripheral blood mononuclear cells in coeliac disease 48
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine? 46
Endocannabinoid system and migraine pain: An update 43
Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing 42
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study 40
Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back 38
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 36
Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: Study in an animal model 34
Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients 32
Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia 31
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms 31
Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine 31
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 29
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine 29
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks 29
Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study 28
Dual inhibition of faah and magl counteracts migraine-like pain and behavior in an animal model of migraine 26
Cd163 as a potential biomarker of monocyte activation in ischemic stroke patients 23
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? 22
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 18
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 9
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine 8
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings 6
The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain 6
Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine 4
URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia 4
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 4
Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine 3
Modelling migraine-related features in the nitroglycerin animal model: Trigeminal hyperalgesia is associated with affective status and motor behavior 2
Totale 998
Categoria #
all - tutte 4.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 44 64 0 2 1 1 0 3 0 7 26 0
2020/202132 2 1 0 5 2 4 3 9 0 5 1 0
2021/2022113 1 0 1 7 0 1 3 9 3 2 14 72
2022/2023442 34 21 19 33 31 49 0 30 204 3 13 5
2023/2024195 22 21 8 13 14 39 1 13 3 8 22 31
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 998